메뉴 건너뛰기




Volumn 81, Issue 1, 2016, Pages 37-40

The enigma of p53

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

EID: 85020989873     PISSN: 00917451     EISSN: 19434456     Source Type: Book Series    
DOI: 10.1101/sqb.2016.81.031062     Document Type: Article
Times cited : (10)

References (46)
  • 2
    • 0345268720 scopus 로고    scopus 로고
    • Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis
    • Alt JR, Greiner TC, Cleveland JL, Eischen CM. 2003. Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J 22: 1442-1450
    • (2003) EMBO J , vol.22 , pp. 1442-1450
    • Alt, J.R.1    Greiner, T.C.2    Cleveland, J.L.3    Eischen, C.M.4
  • 5
    • 84899622427 scopus 로고    scopus 로고
    • Unravelling mechanisms of p53-mediated tumour suppression
    • Bieging KT, Mello SS, Attardi LD. 2014. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14: 359-370
    • (2014) Nat Rev Cancer , vol.14 , pp. 359-370
    • Bieging, K.T.1    Mello, S.S.2    Attardi, L.D.3
  • 6
    • 8844278362 scopus 로고    scopus 로고
    • A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
    • Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, et al. 2004. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119: 591-602
    • (2004) Cell , vol.119 , pp. 591-602
    • Bond, G.L.1    Hu, W.2    Bond, E.E.3    Robins, H.4    Lutzker, S.G.5    Arva, N.C.6    Bargonetti, J.7    Bartel, F.8    Taubert, H.9    Wuerl, P.10
  • 7
    • 70349443284 scopus 로고    scopus 로고
    • When mutants gain new powers: News from the mutant p53 field
    • Brosh R, Rotter V. 2009. When mutants gain new powers: News from the mutant p53 field. Nat Rev Cancer 9: 701-713
    • (2009) Nat Rev Cancer , vol.9 , pp. 701-713
    • Brosh, R.1    Rotter, V.2
  • 9
    • 84975717995 scopus 로고    scopus 로고
    • The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain
    • D'Abramo M, Besker N, Desideri A, Levine AJ, Melino G, Chillemi G. 2016. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain. Oncogene 35: 3272-3281
    • (2016) Oncogene , vol.35 , pp. 3272-3281
    • D'Abramo, M.1    Besker, N.2    Desideri, A.3    Levine, A.J.4    Melino, G.5    Chillemi, G.6
  • 10
    • 70350567735 scopus 로고    scopus 로고
    • 20 years studying p53 functions in genetically engineered mice
    • Donehower LA, Lozano G. 2009. 20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer 9: 831-841
    • (2009) Nat Rev Cancer , vol.9 , pp. 831-841
    • Donehower, L.A.1    Lozano, G.2
  • 13
    • 0025312728 scopus 로고
    • A genetic model for colorectal tumorigenesis
    • Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767
    • (1990) Cell , vol.61 , pp. 759-767
    • Fearon, E.R.1    Vogelstein, B.2
  • 14
    • 0024382760 scopus 로고
    • The p53 proto-oncogene can act as a suppressor of transformation
    • Finlay CA, Hinds PW, Levine AJ. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-1093
    • (1989) Cell , vol.57 , pp. 1083-1093
    • Finlay, C.A.1    Hinds, P.W.2    Levine, A.J.3
  • 16
    • 84862636275 scopus 로고    scopus 로고
    • Mutant p53: One name, many proteins
    • Freed-PastorWA, Prives C. 2012. Mutant p53: One name, many proteins. Genes Dev 26: 1268-1286
    • (2012) Genes Dev , vol.26 , pp. 1268-1286
    • Freed-Pastor, W.A.1    Prives, C.2
  • 21
    • 0028834902 scopus 로고
    • Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
    • Jones SN, Roe AE, Donehower LA, Bradley A. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208
    • (1995) Nature , vol.378 , pp. 206-208
    • Jones, S.N.1    Roe, A.E.2    Donehower, L.A.3    Bradley, A.4
  • 22
    • 0032417695 scopus 로고    scopus 로고
    • Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
    • Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A. 1998. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci 95: 15608-15612
    • (1998) Proc Natl Acad Sci , vol.95 , pp. 15608-15612
    • Jones, S.N.1    Hancock, A.R.2    Vogel, H.3    Donehower, L.A.4    Bradley, A.5
  • 23
    • 0027109075 scopus 로고
    • Cancer. p53, guardian of the genome
    • Lane DP. 1992. Cancer. p53, guardian of the genome. Nature 358: 15-16
    • (1992) Nature , vol.358 , pp. 15-16
    • Lane, D.P.1
  • 25
    • 84884282500 scopus 로고    scopus 로고
    • Switching on p53: An essential role for protein phosphorylation?
    • Loughery J, Meek D. 2013. Switching on p53: An essential role for protein phosphorylation? BioDiscovery 8: 1
    • (2013) BioDiscovery , vol.8 , pp. 1
    • Loughery, J.1    Meek, D.2
  • 29
    • 0028823020 scopus 로고
    • Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
    • Montes de Oca Luna R,Wagner DS, Lozano G. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206
    • (1995) Nature , vol.378 , pp. 203-206
    • Montes de Oca Luna, R.1    Wagner, D.S.2    Lozano, G.3
  • 31
    • 84906084536 scopus 로고    scopus 로고
    • Limiting the power of p53 through the ubiquitin proteasome pathway
    • Pant V, Lozano G. 2014. Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev 28: 1739-1751
    • (2014) Genes Dev , vol.28 , pp. 1739-1751
    • Pant, V.1    Lozano, G.2
  • 32
    • 79961039603 scopus 로고    scopus 로고
    • Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    • Pant V, Xiong S, Iwakuma T, Quintas-Cardama A, Lozano G. 2011. Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. Proc Natl Acad Sci 108: 11995-12000
    • (2011) Proc Natl Acad Sci , vol.108 , pp. 11995-12000
    • Pant, V.1    Xiong, S.2    Iwakuma, T.3    Quintas-Cardama, A.4    Lozano, G.5
  • 33
    • 84971595368 scopus 로고    scopus 로고
    • Distinct downstream targets manifest p53-dependent pathologies in mice
    • Pant V, Xiong S, Chau G, Tsai K, Shetty G, Lozano G. 2016. Distinct downstream targets manifest p53-dependent pathologies in mice. Oncogene doi: 10.1038/onc.2016. 111
    • (2016) Oncogene
    • Pant, V.1    Xiong, S.2    Chau, G.3    Tsai, K.4    Shetty, G.5    Lozano, G.6
  • 34
    • 0034863683 scopus 로고    scopus 로고
    • Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53
    • Parant J, Chavez-Reyes A, Little NA, YanW, Reinke V, Jochemsen AG, Lozano G. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet 29: 92-95
    • (2001) Nat Genet , vol.29 , pp. 92-95
    • Parant, J.1    Chavez-Reyes, A.2    Little, N.A.3    Yan, W.4    Reinke, V.5    Jochemsen, A.G.6    Lozano, G.7
  • 40
    • 84905675480 scopus 로고    scopus 로고
    • Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage
    • Tollini LA, Jin A, Park J, Zhang Y. 2014. Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage. Cancer Cell 26: 235-247
    • (2014) Cancer Cell , vol.26 , pp. 235-247
    • Tollini, L.A.1    Jin, A.2    Park, J.3    Zhang, Y.4
  • 41
    • 85018743075 scopus 로고    scopus 로고
    • Targeting the MDM2-p53 protein-protein interaction for new cancer therapy: Progress and challenges
    • Wang S, Zhao Y, Aguilar A, Bernard D, Yang C. 2016. Targeting the MDM2-p53 protein-protein interaction for new cancer therapy: Progress and challenges. Cold Spring Harb Perspect Med 6: a 026245
    • (2016) Cold Spring Harb Perspect Med , vol.6
    • Wang, S.1    Zhao, Y.2    Aguilar, A.3    Bernard, D.4    Yang, C.5
  • 42
    • 84982786849 scopus 로고    scopus 로고
    • Attenuating the p53 pathway in human cancers: Many means to the same end
    • Wasylishen AR, Lozano G. 2016. Attenuating the p53 pathway in human cancers: Many means to the same end. Cold Spring Harb Perspect Med 6: a 026211
    • (2016) Cold Spring Harb Perspect Med , vol.6
    • Wasylishen, A.R.1    Lozano, G.2
  • 43
    • 33644757727 scopus 로고    scopus 로고
    • Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
    • Xiong S, Van Pelt CS, Elizondo-Fraire AC, Liu G, Lozano G. 2006. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc Natl Acad Sci 103: 3226-3231
    • (2006) Proc Natl Acad Sci , vol.103 , pp. 3226-3231
    • Xiong, S.1    Van Pelt, C.S.2    Elizondo-Fraire, A.C.3    Liu, G.4    Lozano, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.